
CommSec’s Tom Piotrowski speaks with Bionomics Ltd (BNO) CEO & MD, Dr Deborah Rathjen about the company’s newly signed deals with Merck, its new anxiety drug trial and its cancer treatment trials To view more Executive Series interviews, visit: (VIEW LINK)